APRE

APRE

USD

Aprea Therapeutics Inc. Common stock

$1.380+0.020 (1.471%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.360

High

$1.400

Low

$1.360

Volume

0.04M

Company Fundamentals

Market Cap

8.0M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.08M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.31Current $1.380High $5

Related News

GlobeNewswire

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

3 out of 4 patients achieved stable disease (per RECIST v1.1) at the 100 mg APR-1051 dose level in heavily pretreated gastrointestinal and gynecologic malignanciesDisease stabilization observed in patients with tumors

View more
Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051